KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 149 filers reported holding KURA ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $144,306 | -5.4% | 15,823 | +9.8% | 0.00% | 0.0% |
| Q2 2023 | $152,532 | -25.8% | 14,417 | -14.2% | 0.00% | -50.0% |
| Q1 2023 | $205,611 | +3.3% | 16,812 | +4.8% | 0.00% | 0.0% |
| Q4 2022 | $199,106 | -5.2% | 16,044 | +4.2% | 0.00% | 0.0% |
| Q3 2022 | $210,000 | -25.3% | 15,392 | +0.4% | 0.00% | -33.3% |
| Q2 2022 | $281,000 | +14.2% | 15,331 | +0.3% | 0.00% | +50.0% |
| Q1 2022 | $246,000 | +16.0% | 15,292 | +0.8% | 0.00% | 0.0% |
| Q4 2021 | $212,000 | -26.1% | 15,167 | -1.2% | 0.00% | 0.0% |
| Q3 2021 | $287,000 | -10.0% | 15,345 | +0.3% | 0.00% | -33.3% |
| Q2 2021 | $319,000 | -29.6% | 15,298 | -4.6% | 0.00% | -25.0% |
| Q1 2021 | $453,000 | -5.6% | 16,038 | +9.2% | 0.00% | 0.0% |
| Q4 2020 | $480,000 | +6.0% | 14,690 | -0.6% | 0.00% | -20.0% |
| Q3 2020 | $453,000 | +150.3% | 14,776 | +33.4% | 0.01% | +66.7% |
| Q2 2020 | $181,000 | – | 11,077 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |